iShares Biotechnology ETF (NASDAQ:IBB) Position Lowered by Freedom Investment Management Inc.

Freedom Investment Management Inc. reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 55.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,408 shares of the financial services provider’s stock after selling 1,720 shares during the quarter. Freedom Investment Management Inc.’s holdings in iShares Biotechnology ETF were worth $205,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth about $29,000. Highline Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF during the third quarter worth about $30,000. Bbjs Financial Advisors LLC bought a new position in iShares Biotechnology ETF in the second quarter worth about $31,000. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF in the third quarter worth about $36,000. Finally, Voisard Asset Management Group Inc. acquired a new position in iShares Biotechnology ETF in the third quarter valued at approximately $59,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.0 %

Shares of iShares Biotechnology ETF stock opened at $141.55 on Monday. iShares Biotechnology ETF has a twelve month low of $119.95 and a twelve month high of $150.57. The business’s 50 day simple moving average is $142.71 and its 200-day simple moving average is $142.06.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.